Medindia

X

PRA International to Exhibit at ESC's Annual Conference

Monday, August 23, 2010 Press Release J E 4
Advertisement


RALEIGH, N.C., Aug. 23 PRA International, a leading Clinical Research Organization, will exhibit our cardiology expertise and experience at the European Society of Cardiology's (ESC) annual conference in Stockholm, Sweden from 28( )August to 1 September 2010.

At PRA booth C18:62, attendees can schedule meetings with our leading expert in cardiovascular (CV) disease, Dr. Michael Kirchengast, Vice President and Head of Scientific Affairs at PRA, to learn how PRA can support drug development projects.

In addition to his ESC attendance, Dr. Kirchengast is also hosting a CV audio conference on 24 August 2010 at 11:30 am (EDT). Those wishing to attend this session can learn key concepts and explore new strategies for preventing some of the expensive failures that pharmaceutical companies experience during late-stage development.

Dr. Kirchengast has 30 years of experience in CV research and development, including interactions with multiple authorities. His wide range of development experience encompasses antiarrhythmics, antithrombotics, antihypertensives, antihyperlipidemics, heart failure therapeutics, and vascularly active and cardioprotective drugs.

Additional PRA representatives, including Dr. Margit Banagl, Executive Director of Medical Affairs, will be at ESC to provide information on the full breadth of PRA's services.

For more information about our ESC exhibit and Dr. Kirchengast's audio conference, navigate to www.praintl.com and click on "Events." To register for the audio conference, email endpoints@praintl.com.

About PRA International

PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology/Hematology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on-time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Beehive-eating Labrador Retriever Takes Home 2nd A...
S
Kendle Appoints Jeffrey M. Zucker to Lead Global P...